These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2894289)

  • 1. Clinical observations of agonist-antagonist analgesic dependence.
    Peachey JE
    Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects and analgesic efficacy of the agonist-antagonist opioids.
    Zola EM; McLeod DC
    Drug Intell Clin Pharm; 1983 Jun; 17(6):411-7. PubMed ID: 6861632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical usefulness of agonist-antagonistic opioid analgesics in chronic pain.
    Hanks GW
    Drug Alcohol Depend; 1987 Dec; 20(4):339-46. PubMed ID: 2894288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Full ยต-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC; Schneider J; Tzschentke TM
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid agonist/antagonists in general anaesthesia.
    Wilkinson DJ
    Br J Hosp Med; 1987 Aug; 38(2):130-3. PubMed ID: 2888499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse liability studies of opioid agonist-antagonists in humans.
    Preston KL; Jasinski DR
    Drug Alcohol Depend; 1991 Jun; 28(1):49-82. PubMed ID: 1884671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of nalbuphine hydrochloride.
    Miller RR
    Am J Hosp Pharm; 1980 Jul; 37(7):942-9. PubMed ID: 6994499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical usefulness of agonist-antagonist analgesics in acute pain.
    Rosow CE
    Drug Alcohol Depend; 1987 Dec; 20(4):329-37. PubMed ID: 2894287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine.
    Gringauz M; Rabinowitz R; Stav A; Korczyn AD
    J Anesth; 2001; 15(4):204-9. PubMed ID: 14569437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which potent opioid? Important criteria for selection.
    Bovill JG
    Drugs; 1987 May; 33(5):520-30. PubMed ID: 2954811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.
    Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
    Neurosci Lett; 2003 Nov; 351(1):5-8. PubMed ID: 14550900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.